Total Payments
$346.05
2024 Payments
$53.19
Companies
7
Transactions
20
Medicare Patients
9,333
Medicare Billing
$989,819
Payment Breakdown by Category
Food & Beverage$346.05 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $346.05 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $146.47 | 9 | $0 (2018) |
| Novo Nordisk Inc | $81.33 | 5 | $0 (2024) |
| ABBVIE INC. | $48.03 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $26.41 | 1 | $0 (2023) |
| Lilly USA, LLC | $17.23 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $14.59 | 1 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $11.99 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.19 | 3 | Novo Nordisk Inc ($28.83) |
| 2023 | $63.10 | 3 | Novo Nordisk Inc ($36.69) |
| 2021 | $17.23 | 1 | Lilly USA, LLC ($17.23) |
| 2020 | $14.59 | 1 | Janssen Pharmaceuticals, Inc ($14.59) |
| 2019 | $39.48 | 2 | AbbVie, Inc. ($23.67) |
| 2018 | $17.87 | 1 | Amgen Inc. ($17.87) |
| 2017 | $140.59 | 9 | Amgen Inc. ($128.60) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes | ||||||
| 02/22/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Diabetes | ||||||
| 01/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Diabetes | ||||||
| 08/19/2019 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Endocrinology | ||||||
| 07/25/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Endocrinology | ||||||
| 11/01/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Endocrinology | ||||||
| 10/13/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Endocrinology | ||||||
| 09/22/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Endocrinology | ||||||
| 08/04/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Endocrinology | ||||||
| 06/23/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Endocrinology | ||||||
| 03/23/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Endocrinology | ||||||
| 02/22/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Endocrinology | ||||||
| 01/26/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,711 | 4,082 | $1.2M | $281,267 |
| 2022 | 26 | 2,403 | 3,850 | $1.1M | $258,049 |
| 2021 | 26 | 2,112 | 3,724 | $952,089 | $243,824 |
| 2020 | 20 | 2,107 | 3,559 | $543,704 | $206,678 |
Total Patients
9,333
Total Services
15,215
Medicare Billing
$989,819
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 479 | 1,259 | $502,424 | $75,520 | 15.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 247 | 250 | $213,000 | $70,393 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 374 | 374 | $151,470 | $50,539 | 33.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 209 | 214 | $47,936 | $16,162 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 107 | 134 | $74,923 | $12,920 | 17.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 37 | $31,801 | $8,465 | 26.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 240 | 245 | $12,005 | $7,620 | 63.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 376 | 376 | $22,184 | $7,351 | 33.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 225 | 230 | $11,270 | $7,153 | 63.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 31 | 31 | $16,089 | $5,379 | 33.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 29 | $18,560 | $4,971 | 26.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 54 | 84 | $19,570 | $4,696 | 24.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $6,734 | $2,251 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,742 | $1,397 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 27 | $7,510 | $1,056 | 14.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 76 | 82 | $3,772 | $943.25 | 25.0% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 14 | 22 | $4,163 | $899.63 | 21.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 16 | 17 | $2,584 | $687.82 | 26.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 60 | $2,700 | $659.91 | 24.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 13 | $2,132 | $570.44 | 26.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 16 | $2,096 | $560.16 | 26.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 21 | 21 | $1,389 | $457.47 | 32.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 68 | 514 | $2,056 | $443.21 | 21.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 23 | 23 | $1,058 | $171.50 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 473 | 1,202 | $499,656 | $83,849 | 16.8% |
About Dr. Robert Rapp, MD
Dr. Robert Rapp, MD is a Internal Medicine healthcare provider based in Havre De Grace, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720081003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Rapp, MD has received a total of $346.05 in payments from pharmaceutical and medical device companies, with $53.19 received in 2024. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($346.05).
As a Medicare-enrolled provider, Rapp has provided services to 9,333 Medicare beneficiaries, totaling 15,215 services with total Medicare billing of $989,819. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Havre De Grace, MD
- Active Since 05/31/2005
- Last Updated 12/18/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720081003
Products in Payments
- Prolia (Biological) $146.47
- Rybelsus (Drug) $65.52
- TRELEGY ELLIPTA (Drug) $26.41
- UBRELVY (Drug) $24.36
- Androgel (Drug) $23.67
- TRULICITY (Drug) $17.23
- Ozempic (Drug) $15.81
- XARELTO (Drug) $14.59
- UTIBRON (Drug) $11.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Havre De Grace
Dr. Thomas Biondo, M.d, M.D
Internal Medicine — Payments: $14,095
Internal Medicine $14,095
Dr. Hi Sim, M.d, M.D
Internal Medicine — Payments: $13,591
Internal Medicine $13,591
Dr. Shristi Neupane, Md, MD
Internal Medicine — Payments: $4,753
Internal Medicine $4,753
Dr. Benjamin Lee, M.d, M.D
Internal Medicine — Payments: $1,720
Internal Medicine $1,720
Dr. Suresh Dhanjani, M.d, M.D
Internal Medicine — Payments: $96.70
Internal Medicine $96.70
Dr. Matt Wachsman, Md Phd, MD PHD
Internal Medicine — Payments: $78.89
Internal Medicine $78.89